Biocept DSO Ratio 2011-2026 | BIOC

Annual DSO Ratio Biocept

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
112	83.2	188	233	177	85.9	14.6	20.5	29	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
233	14.6	105

Quarterly DSO Ratio Biocept

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
148	221	-	271	264	68.9	-	74.6	113	80.4	-	196	1.41 K	557	180	210	270	227	167	189	175	156	109	98	85.2	35.9	9.11	11.2	17.8	33.6	14.3	18.9	40.6	13.6	12.8	94.2	50.3	31.9	44.6	26.3	17.4	11.9	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.41 K	9.11	148

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Co-Diagnostics CODX	94.7	$ 1.59	1.27 %	$ 2.12 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	49.2	$ 24.6	-3.61 %	$ 683 M	USA
Fulgent Genetics FLGT	77.4	$ 14.9	-1.46 %	$ 451 M	USA
Agilent Technologies A	63.8	$ 117.53	4.77 %	$ 35.7 B	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
CareDx, Inc CDNA	51.5	$ 20.7	-1.24 %	$ 1.1 B	USA
Illumina ILMN	61.3	$ 139.07	-0.22 %	$ 22.1 B	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Lantheus Holdings LNTH	80.5	$ 85.82	-2.23 %	$ 5.79 B	USA
Medpace Holdings MEDP	50.4	$ 430.32	3.19 %	$ 12.4 B	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Neogen Corporation NEOG	66.6	$ 9.27	1.98 %	$ 2.01 B	USA
National Research Corporation NRC	29.4	$ 18.74	2.85 %	$ 419 M	USA
ICON Public Limited Company ICLR	68.5	$ 121.32	8.35 %	$ 10 B	Irlanda
Personalis PSNL	55.8	$ 5.56	-5.76 %	$ 329 M	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	65	$ 185.39	7.58 %	$ 9.19 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Guardant Health GH	46.1	$ 89.52	-1.81 %	$ 11.2 B	USA
Myriad Genetics MYGN	52.3	$ 5.03	1.82 %	$ 466 M	USA
NeoGenomics NEO	77.7	$ 8.86	-1.56 %	$ 1.13 B	USA
Thermo Fisher Scientific TMO	70	$ 466.76	0.9 %	$ 176 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Interpace Biosciences IDXG	66.9	$ 2.01	0.4 %	$ 8.89 M	USA
Senseonics Holdings SENS	10.3	$ 5.0	-0.2 %	$ 209 M	USA
Soleno Therapeutics SLNO	27	$ 52.92	0.04 %	$ 2.69 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Twist Bioscience Corporation TWST	44.5	$ 56.7	0.91 %	$ 3.39 B	USA
Biomerica BMRA	57.7	$ 2.19	1.16 %	$ 5.03 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 257.14	1.64 %	$ 21.4 B	USA
Natera NTRA	81.5	$ 206.77	-2.26 %	$ 20.3 B	USA
Burning Rock Biotech Limited BNR	31.7	$ 17.02	-0.96 %	$ 180 M	China
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
Quest Diagnostics Incorporated DGX	44.9	$ 190.84	-0.34 %	$ 21.2 B	USA
Waters Corporation WAT	306	$ 342.75	13.54 %	$ 20.4 B	USA